Skip to main content

Day: January 9, 2025

Photocat A/S and Essity Announce Partnership to Bring Sustainable Dust-Suppression Solution, InnoLig+©, to Key European Markets

January 9, 2025        Photocat A/S and Essity Announce Partnership to Bring Sustainable Dust-Suppression Solution, InnoLig+©, to Key European Markets Roskilde, Denmark. January 9, 2025 – Photocat A/S, a leading innovator in sustainable photocatalytic solutions as well as de-icing and dust-suppression products, is proud to announce a distribution and commercial partnership with Essity, a global leading hygiene and health company. This collaboration focuses on introducing InnoLig+©, a sustainable lignin-based dust-suppression solution, to key European markets, including the Nordics, Germany, United Kingdom, Poland, Baltics, Switzerland, and Spain. The partnership aims to meet the growing demand for effective and environmentally friendly dust-suppression technologies across Europe. The Serious Impact of Dust on Human Health: Dust pollution...

Continue reading

Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region

Jie XueÖzlem FidanciJanuary 9, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the appointment of Jie Xue as Chief Business Leader Precision Diagnosis, and Özlem Fidanci as Chief of International Region, both effective January 1, 2025. Ms. Xue and Ms. Fidanci have joined Philips’ Executive Committee and report directly to Roy Jakobs, CEO of Philips. Ms. Xue joins Philips from GE Healthcare to lead the Precision Diagnosis business that was temporarily led by Bert van Meurs, who will continue to lead Philips’ Image Guided Therapy business. Ms. Xue and Mr. Van Meurs will be jointly responsible for the Diagnosis & Treatment segment. Ms. Fidanci joins from Versuni and succeeds Edwin Paalvast, Chief of International Region, who has decided...

Continue reading

Ultimovacs ASA – Extraordinary General Meeting held on January 9, 2025

Oslo, January 9, 2025: Ultimovacs ASA held its extraordinary general meeting today January 9, 2025. All the matters on the agenda were approved. The minutes from the meeting are enclosed and available at the company’s website. For further information, please see www.ultimovacs.com or contact: Jónas Einarsson, Chair of the Board of Directors of Ultimovacs ASA Email: je@radforsk.no Phone: +47 480 96 355 Hans Vassgård Eid, CFO and Interim CEO, Ultimovacs ASA Email: hans.eid@ultimovacs.com Phone: +47 482 48632AttachmentMinutes of the Extraordinary General Meeting 2025 in Ultimovacs ASA

Continue reading

Final terms for bonds to be listed 10th January 2025

To Nasdaq Copenhagen A/S                        9th January 2025                                        Announcement no. 3/2025 Final terms for bonds to be listed 10th January 2025 On 10th January 2025, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bonds consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated June 28th, 2024. Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com Yours sincerely,Jyske Realkredit A/S www.jyskerealkredit.com Please...

Continue reading

ISS announces changes to the Executive Group Management Team

Company Announcement Copenhagen, 9 January 2025 No. 3/2025 ISS announces changes to the Executive Group Management Team ISS A/S, a leading workplace experience and facility management company, today announces changes to the Executive Group Management team. ISS A/S launched the OneISS strategy in 2020 and in December 2024, ISS reviewed certain elements of the strategy. To successfully implement the strategic priorities the Executive Group Management Team will be reduced from 8 to 5 members. As part of the changes, three of the existing Executive Group Management members will have a changed responsibility:Carl-Fredrik Bjor, will take up the role as Chief Commercial & Revenue Officer and drive the commercial agenda locally as well as globally. Liz Benison, will take up the role as Chief People and Technology Officer to further build...

Continue reading

Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million

COPENHAGEN, Denmark, January 9, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a share buy-back program of up to DKK 150 million as announced on December 11, 2024. The decision to launch the program is driven by a better-than-expected performance and improved visibility pertaining to the Company’s Travel Health business, with synergies from a number of recent and near-term expected events as described in the December 11 announcement. Bavarian Nordic will hold the shares bought back as treasury stock, for the purpose of adjusting the capital structure and meeting the long-term obligations relating to the Company’s share-based incentive programs for the Board of Directors and Executive Management. The share buy-back program is initiated pursuant to the authorization granted at the annual general meeting on April...

Continue reading

Dékuple accelerates its european expansion with majority stakes in Selmore (Amsterdam) and DotControl (Rotterdam)

Dékuple accelerates its european expansion with majority stakes in Selmore (Amsterdam) and DotControl (Rotterdam) A strategic partnership to continue building a next-generation agency model in Europe Paris, January 9, 2025 (8:00 am) – The creative agency Selmore and the digital agency DotControl are joining forces with the Dékuple Group, European leader in data marketing and communication. The integration of these two new entities into Dékuple’s multi-entrepreneur model represents a significant milestone in the Group’s external growth strategy, aimed at strengthening its footprint in Europe and expanding its expertise portfolio to better serve its international clients. This partnership further reinforces Dékuple’s commitment to becoming a leading player in communication and data marketing across Europe. Selmore, a strategic...

Continue reading

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myeloma

New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in multiple myelomaSarclisa SC formulation added to Pd for the treatment of R/R MM met the co-primary endpoints in the IRAKLIA phase 3 study, demonstrating non-inferiority compared to Sarclisa IV IRAKLIA is the first global phase 3 study to evaluate the SC administration of a cancer treatment via an OBDS OBDS is an alternative delivery method designed to improve the patient experience and currently available SC administrationParis, January 9, 2025. Results from the investigational, randomized, open-label IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (SC) via an on-body delivery system (OBDS) in combination with pomalidomide and dexamethasone (Pd) met its co-primary endpoints of non-inferior objective...

Continue reading

TGS Q4 2024 Operational Update

TGS Q4 2024 Operational Update OSLO, Norway (9 January 2025) – TGS, a leading global provider of energy data and intelligence routinely publishes a quarterly operational update six working days after quarter-end. The table below shows TGS’s normalized Ocean Bottom Node (OBN) crew count:    2022 2023 2024Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4Normalized crewcount1   2.9   3.2   3.2   2.3   2.6   3.2   3.2   1.9   1.9   2.7   3.8   3.51) The table shows average number of crews in operation when assuming a normalized crew size. In Q4 2024 all crews were used for contract work. If crews are used for multi-client in the future that will be disclosed.   The table below shows TGS’s streamer vessel allocation:Allocation of active seismic 3D vessel capacity2     2022     2023     2024  Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4Contract...

Continue reading

AS Tallinna Sadam operational volumes for Q4 and 2024 full year

In 2024 Q4, 1.9 million passengers and 3.4 million tons of cargo passed through the harbors of Tallinna Sadam. Compared to the same period of previous year, the number of passengers increased by 4.8% supported by Finnish lines and the cargo volume increased by 11.7%, most of it in dry bulk and containers. The number of vessel calls increased by 4.8% reaching 1857 calls. The number of passengers travelling between the Estonian mainland and the main islands increased by 4.3% and the number of vehicles increased by 6.0%. The utility rate of the icebreaker Botnica was 55% decreasing by 12 percentage points. In 2024, more than 13 million tons of cargo and 8 million passengers passed through the harbors of Tallinna Sadam. The annual number of cargo volume increased by 4.4% and number of passengers 3.6%. The number of vessel calls increased by...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.